Live tape
Top 8, mentions 7d12,694TSLA3,043 mentions▲ +0.05SPCX2,537 mentions▲ +0.08GOOGL1,670 mentions▲ +0.03META1,497 mentions▲ +0.05NVDA997 mentions▲ +0.07CRWV987 mentions▲ +0.04QQQ987 mentions▲ +0.05NFLX976 mentions▲ +0.03

Equity · Real Estate

SBRA

NASDAQ

Sabra Health Care REIT (SBRA)

$20.11 +0.55% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SBRA to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $5.1B
P/E (TTM) 77.4
52-week range $17.24 – $21.21
Avg volume 962.7K

as of Jul 17, 2026

Sabra Health Care REIT (SBRA) insider trades

SEC Form 4 · last 90 days · newest reported trade 8 Sep 2026

In the 90 days to 22 Oct 2026, Sabra Health Care REIT insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 28 Nov 2025, show no open-market purchase.

Open-market buys 0
Open-market sells 1
Net sold $4.17M
Non-trade filings 10
Date Insider Type Shares Value
08 Sep 2026 MATROS RICHARD K Chair, CEO and President Sell 200,000 $4.17M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
31 Aug 2026 Barbarosh Craig A. Director Award 791
31 Aug 2026 Costa Michael Lourenco Executive VP, CFO & Treasurer Award 4,158
31 Aug 2026 Cusack Catherine Director Award 791
31 Aug 2026 FLORES JESSICA Executive VP & CAO Award 382
31 Aug 2026 FOSTER MICHAEL J Director Award 791
31 Aug 2026 KATZMANN LYNNE S Director Award 791
31 Aug 2026 Kono Ann Director Award 791
31 Aug 2026 MATROS RICHARD K Chair, CEO and President Award 13,867
31 Aug 2026 Malehorn Jeffrey A. Director Award 791
31 Aug 2026 Smith Darrin Executive VP, CIO & Secretary Award 495

Sabra Health Care REIT (SBRA) reported financials

SEC EDGAR XBRL SEC EDGAR

Sabra Health Care REIT reported revenue of $356.9M for the fiscal year ended 31 Dec 2025. Net income over the same period was $155.6M.

Figure Reported Period
Revenue $356.9M 31 Dec 2025 fiscal year
Net income $155.6M 31 Dec 2025 fiscal year
Diluted EPS $0.64 31 Dec 2025 fiscal year
Total assets $5.5B 30 Jun 2026 at period end
Total equity $2.8B 30 Jun 2026 at period end

Sabra Health Care REIT (SBRA) earnings

SEC EDGAR

Sabra Health Care REIT last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.10; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.10 $236M
31 Mar 2026 Q1 2026 $0.16 $222M
31 Dec 2025 FY 2025 $0.64 $775M
30 Sep 2025 Q3 2025 $0.09 $190M
30 Jun 2025 Q2 2025 $0.27 $189M
31 Mar 2025 Q1 2025 $0.17 $184M
31 Dec 2024 FY 2024 $0.54 $703M
30 Sep 2024 Q3 2024 $0.13 $178M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Sabra Health Care REIT (SBRA) institutional holders (13F)

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a Sabra Health Care REIT position for the quarter ended 30 Jun 2026 — a combined $157.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +41.4% shares 1,998,848 $39.0M
Two Sigma Investments Held (±25%) −22.3% shares 1,947,826 $38.0M
Point72 Asset Management Added +99.0% shares 1,115,011 $21.8M
D. E. Shaw & Co. Held (±25%) −10.6% shares 833,693 $16.3M
Millennium Management Trimmed −52.9% shares 746,172 $14.6M
Tudor Investment Corp Added +1,070.4% shares 631,543 $12.3M
Citadel Advisors Held (±25%) −15.5% shares 530,392 $10.3M
Marshall Wace Added +25.5% shares 135,438 $2.6M
Man Group New position 103,321 $2.0M
Balyasny Asset Management Added +279.0% shares 53,074 $1.0M

Sabra Health Care REIT (SBRA) fails-to-deliver

SEC CNS data SEC

On 11 Sep 2026, 181,086 shares of Sabra Health Care REIT failed to deliver (about $3.8M).

Settlement date Shares failed Notional % of shares out
11 Sep 2026 181,086 $3.8M 0.071%

Congressional trades in Sabra Health Care REIT (SBRA)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Sabra Health Care REIT is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

Date Member Type Amount
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K
01 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Purchase $1K–$15K
08 Nov 2022 filed 12 Dec 2022 Sara Jacobs house · Democrat–CA Sale $1K–$15K

Sabra Health Care REIT (SBRA): frequently asked questions

From live data

Have Sabra Health Care REIT insiders bought or sold shares recently?

In the 90 days to 22 Oct 2026, Sabra Health Care REIT insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 28 Nov 2025, show no open-market purchase. A further 10 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Sabra Health Care REIT?

10 of the 45 institutional funds we track reported a Sabra Health Care REIT position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Sabra Health Care REIT had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Sabra Health Care REIT is dated 11 Sep 2026, when 181,086 shares failed to deliver.

When did Sabra Health Care REIT last report earnings?

Sabra Health Care REIT last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.10; no next date is announced in SEC filings yet.

What exchange is Sabra Health Care REIT listed on?

Sabra Health Care REIT trades on NASDAQ under the ticker SBRA.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings